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Abstract
Glioma is a common type of primary brain tumor, with a strongly invasive potential, often exhibiting
nonuniform, highly irregular growth. This makes it difficult to assess the degree of extent of the
tumor, hence bringing about a supplementary challenge for the treatment. It is therefore necessary to
understand the migratory behavior of glioma in greater detail. In this paper we propose a multiscale
model for glioma growth and migration. Our model couples the microscale dynamics (reduced to
the binding of surface receptors to the surrounding tissue) with a kinetic transport equation for
the cell density on the mesoscopic level of individual cells. On the latter scale we also include the
proliferation of tumor cells via effects of interaction with the tissue. An adequate parabolic scaling
yields a convection-diffusion-reaction equation, for which the coefficients can be explicitly determined
from the information about the tissue obtained by diffusion tensor imaging. Numerical simulations
relying on DTI measurements confirm the biological findings that glioma spreads along white matter
tracts.
1 Introduction
Tumor migration and proliferation are two of the most injurious features of cancer, as they happen in
detriment of normal tissue. Therefore, the current therapy strategies aim at stopping or at least slowing
down these processes. For this in turn, a thorough understanding of the involved phenomena is required.
In the last decades mathematical modeling in combination with qualitative and quantitative biological
knowledge has become a valuable tool for shading light on many biochemical events involved in cancer
development, allowing to make predictions about the evolution of the investigated processes, suggest new
experimental settings or even improve therapy approaches.
The invasion of tumor cells into healthy tissue is a highly complex process involving several levels, from
the microscopic, intracellular through the intercellular and up to the macroscopic level of a cell population
[26]. Most of the events taking place on the various scales are still not completely understood and are part
of ongoing research [21]. Mathematical models - simplified to account only for the main features of the
invasion process - aim at facilitating reliable information about the tumor in order to provide the optimal
therapy. In the present paper we focus on predicting the migratory patterns of glioma, thereby paying
particular attention to both cell dispersal along anisotropic structures of the brain and to proliferation.
Gliomas are tumors arising from glia cells. The most common and most aggressive type of primary brain
tumour, glioblastoma multiforme, has a poor prognosis. The prevailing therapy is surgery, but the tumor
is usually infiltrative, which makes complete resection difficult. Radiotherapy (possibly after or concurrent
to chemotherapy) can be used to improve the treatment outcome, but it needs, too, informations about
the (often very diffuse) shape of the astrocytoma to be irradiated. It is believed that the observed
fingering patterns and fibrillar difffusion [13, 16, 23, 40] are due to the glioma following white matter
tracts [15, 24, 25] made up of neuron bundles.
Diffusion tensor imaging (DTI) is a common radiological method for tumor diagnosis [46]. It is able
to extract neural tract directional information from the measurements of anisotropic diffusion of water
molecules in the brain tissue, as the latter is more effective along the aligned fibers than orthogonally to
them. This means that the measured rate of diffusion will vary depending on the respective direction.
For more details concerning DTI we refer to [3, 17, 48] and for their use in connection to mathematical
models for glioma spread we refer to [12, 18, 19, 28, 33, 35, 42]. Most of the mathematical approaches
developed so far for this problem are dealing with the macroscopic scale of the tumor and use reaction-
diffusion equations (possibly with space and time dependent diffusion coefficients, or accounting for the
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interaction with the surrounding tissue by letting the diffusion coefficient be proportional to the water
diffusion tensor assessed by DTI) to characterize the glioma density [9, 11, 33, 35, 47, 51]. More advanced
settings [28, 42] do not assume the form of the macroscopic equation and its coefficients, but deduce them
from a more detailed modeling on the mesoscale of individual cells, on which they set a kinetic transport
equation for the density of glioma depending not only on time and space, but also on the velocity of cells.
A scaling argument allows then to deduce the macroscopic equation for the population density of cancer
cells. While all these models are set on a single (macroscopic or mesoscopic) scale, the latter approach has
been recently extended in [18, 19] to a multiscale framework accounting for the subcellular (microlevel)
dynamics and connecting it to the mesoscopic evolution of glioma density. An adequate scaling led again
to the population level dynamics explicitly carrying the subcellular level information and introducing a
supplementary (haptotactic) drift in the macroscale behavior of the tumor. In the present note we retake
the modeling approach in [18, 19] and pay particular attention to the description of cell proliferation.
Usually, it is realized by a simple choice of the source term (e.g., logistic, Gompertzian, exponential, etc.)
on the macroscopic level, which is, again, an assumption inducing supplementary uncertainties in the
model and restraining its versatility. This issue has been addressed in [19], where the cell proliferation
was characterized relying on the “go-or-grow” hypothesis stating that cancer cells can either move or
proliferate [8, 24, 29]. Thereby, the mesolevel transitions between moving and resting regimes played an
essential role. As in [18, 28, 42], a parabolic scaling allowed to pass to the macrolevel formulation, in
which the logistic growth is a particular case for the description of the source term. Here we propose a
new way of modeling proliferation, without necessarily following the “go-or-grow” assumption. Instead,
we use cell-tissue interactions to include the proliferation on the mesoscale via microscale dynamics.
The paper is structured as follows: in the next section we introduce our modeling approach. Section 3
deals with the macroscopic scaling, leading to the population dynamics, whose well posedness is addressed
as well. The choice of the model parameters for the numerical simulations is motivated in section 4.
Section 5 provides the numerical results illustrating the behavior of the glioma density characterized with
the macroscopic equation deduced in section 3. Finally, in section 6 we discuss on the performance and
the perspectives of our model.
2 Model set up
Our model setting involves two different scales: On the microscale it accounts for processes taking place
on the subcellular level. Here these reduce to the binding of cell surface receptors (integrins) to unsoluble
ligands in the tumor environment and the corresponding mass action kinetics are characterized by an
ordinary differential equation (ODE) written for the concentration of bound integrins. The mesoscale
accounts for the behavior of individual cells and their interactions with the underlying (anisotropic) tissue.
Integrins are heterodimeric transmembrane surface proteins involved -upon activation- in several signaling
pathways relevant for glioma behavior, including proliferation, motility, invasion, survival [30, 32, 37]. In
our model we regard integrin activation (binding to tissue) as the onset of proliferation and reorientation.
The binding dynamics is characterized with the following simple ODE:
y˙ = k+(R0 − y)A− k−y =: G(y,Q), (1)
where y represents the concentration of bound integrins, R0 denotes the total amount of receptors on the
cell (we assume it is conserved), and the constants k+ and k− denote the reaction rates for the reversible
binding of integrins to the tissue fibres. The macroscopic quantity Q represents the volume fraction of
tissue (including ECM and brain fibers), see [18, 19].
On the mesoscale we use a kinetic transport equation to describe the behavior of the glioma density in
the form of a density function p(t,x,v, y) depending on time t, position x ∈ Rn, velocity v ∈ V ⊂ Rn,
and internal state1 y ∈ Y ⊂ R. In the absence of proliferation, this equation takes the form
∂tp+∇x · (vp) + ∂y(G(y,Q)p) = L[λ]p, (2)
where L[λ]p := −λ(y)p + λ(y) ∫
V
K(x,v)p(v′)dv′ denotes the turning operator modeling the reorienta-
tions of cells due to contact guidance by tissue. Thereby, λ(y) is the turning rate of cells, depending as in
[18, 19] on the amount of bound integrins, and K is the turning kernel carrying the tissue influence. Here
it is assumed to take the particular form K(x,v) = q(x,vˆ)ω , where vˆ is the normalized velocity, q(x, vˆ) is
the directional distribution of tissue fibers2, and ω =
∫
V
q(vˆ)dv = sn−1 is a scaling constant making K
1we will use throughout this paper the slightly abusive formulation “internal state” to refer to the bound integrins
2hence we also assume these fibers to be undirected
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a genuine probability kernel.
As it is difficult to solve numerically the above equations and since the informations about the tumor are
assessed on the level of organs and tissue, we aim at deducing a macroscopic equation for the behavior
of the glioma population. This amounts to providing an adequate moment closure for the macroscopic
scaling. Here we use an ad-hoc closure, assuming that the subcellular dynamics is very fast, hence y is
close to the steady state y∗ of (1). Following [18, 19], we introduce a new internal variable z := y∗ − y
measuring deviations from this steady state. This transforms equation (2) into
∂tp+ v · ∇p+ ∂z
((−(k+Q+ k−)z + f ′(Q)v · ∇Q) p) = L[λ0]p+ L[λ1]zp, (3)
where
f(Q(x)) =
k+Q(x)R0
k+Q(x) + k−
(4)
and we chose λ(z) = λ0 − λ1z ≥ 0, with λ0 and λ1 some positive constants 3.
Next we want to model cell proliferation. This was done in [19] by making use of the “go-or-grow”
dichotomy, considering two subpopulations of cancer cells: moving and resting (i.e., proliferating), re-
spectively. The transitions between these populations along with supplementary source and decay terms
characterized their dynamics. While the “go-or-grow” hypothesis has been endorsed by many studies,
there are, however, quite a few works, too, providing evidence of proliferation not being deferred for
migration (see e.g., [14, 22, 41, 50]), thus preserving its controversial character. In order to avoid such
issues we renounce the “go-or-grow” conjecture and try instead to model proliferation just as an effect of
cell-tissue interactions (via integrin binding), as announced above.
A way to include proliferation on the mesoscale is to consider a source term of the form
P(p) = µ (x, p¯,v)
∫
Z
χ(x, z, z′)p(t,x,v, z′)Q(x) dz′, (5)
where p¯(t,x) =
∫
V
∫
Z
p(t,x,v, z) dv dz denotes the macroscopic cell density on which the growth rate µ
depends. Thereby, the domain for the internal dynamics is Z ⊆ [y∗ − R0, y∗]. The integral operator in
(5) involves a kernel χ characterizing the transition from the state z′ to the state z during a proliferative
action. We do not require χ to be symmetric in the second and third variable nor state any mean value
conditions. So this term is rather general, but we will assume the nonlinear operator P to be uniformly
bounded in the L2 norm. This assumption is reasonable, as space constraints impose bounds on the cell
division. The form (5) is motivated by the so-called proliferative interactions in the kinetic theory of
active particles (KTAP) framework introduced by Bellomo [6, 7]. Such interaction is modelled here by
the product between the mesoscopic density p of tumor cells and the (macroscopic) volume fraction of
tissue Q. As mentioned above, we see the cell-tissue interactions (expressed on the microscale by integrin
binding) as the onset of proliferation, whence the dependency of χ on z. The proliferation rate µ is
assumed to be limited, e.g., by the local competition of tumor cells. A couple of concrete forms will be
given in Subsection 4.3. As previously in [19], we ignore cell-cell interactions.
Then our kinetic transport equation on the mesoscale becomes
∂tp+∇ · (vp)− ∂z(((k+Q+ k−)z − f ′(Q)v · ∇Q)p) = L[λ0]p− L[λ1]zp+ P(p). (6)
Remark 2.1 Equation (6) aligns to the setting in [34, 38], and the global existence of a unique solution
can be proved as in [38], provided µ satisfies an appropriate growth condition w.r.t. its third argument.
3 Macroscopic scaling
In this section we perform a parabolic scaling in order to convert (6) to a macroscopic equation for the
cell population density p¯(t,x), hence reducing the dimension of the phase space. This is particularly
useful for the subsequent numerical simulations, as it is hardly possible to measure initial values with
respect to the speed v or the deviation z from the steady state of bounded receptors.
3this choice corresponds to the observation that the cell turning rate increases with the amount of bound integrins
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Define the variables
m(t,x,v) =
∫
Z
p(t,x,v, z) dz M(t,x) =
∫
V
m(t,x,v) dv = p¯(t,x)
mz(t,x,v) =
∫
Z
zp(t,x,v, z) dz Mz(t,x) =
∫
V
mz(t,x,v) dv
and assume the data to be compactly supported in the (x,v, z) space, which justifies the subsequent
calculations.
As in [18, 19], integrate (6) w.r.t. z. Then multiply (6) by z and integrate again w.r.t. z. The higher
(starting from the second) order moments of p w.r.t. z can be neglected due to our assumption of small
deviations from the steady state of (1). These steps lead to the equations
∂tm+∇x · (vm) = −λ0m+ λ1mz + λ0 q
ω
M − λ1 q
ω
Mz
+ µ(x,M,v)
∫
Z
∫
Z
χ(x, z, z′)p(z′)Q(x) dz′ dz
∂tm
z +∇x · (vmz) = −(k+Q+ k−)mz + f ′(Q)v · ∇Qm− λ0mz + λ0 q
ω
Mz
+ µ(x,M,v)
∫
Z
∫
Z
zχ(x, z, z′)p(z′)Q(x) dz′ dz.
3.1 Formal parabolic limit
Now use tˆ = 2t, xˆ = x to rescale the time and space variables. Moreover, the proliferation rate is
rescaled with 2 to let it act on the correct new time scale. After dropping the hats on the new variables
for simplicity of writing we obtain
2∂tm+ ∇ · (vm) = −λ0m+ λ1mz + λ0 q
ω
M − λ1 q
ω
Mz
+ 2µ(x,M,v)
∫
Z
∫
Z
χ(x, z, z′)p(z′)Q(x) dz′ dz (7)
2∂tm
z + ∇ · (vmz) = −(k+Q+ k− + λ0)mz + λ0 q
ω
Mz + f ′(Q)v · ∇Qm
+ 2µ(x,M,v)
∫
Z
∫
Z
zχ(x, z, z′)p(z′)Q(x) dz′ dz. (8)
With the Hilbert expansions
m =
∞∑
k=0
kmk M =
∞∑
k=0
kMk
mz =
∞∑
k=0
kmzk M
z =
∞∑
k=0
kMzk
we obtain by collecting the coefficients of the powers of :
0 :
0 = −λ0m0 + λ1mz0 + λ0
q
ω
M0 − λ1 q
ω
Mz0
0 = −(λ0 + k+Q+ k−)mz0 + λ0
q
ω
Mz0
1 :
∇ · (vm0) = −λ0m1 + λ1mz1 + λ0
q
ω
M1 − λ1 q
ω
Mz1
∇ · (vmz0) = −(λ0 + k+Q+ k−)mz1 + λ0
q
ω
Mz1 + f
′(Q)∇ · (vQ)m0
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2 :
∂tm0 +∇ · (vm1) = −λ0m2 + λ1mz2 + λ0
q
ω
M2 − λ1 q
ω
Mz2 + µ(x,M,v)
∫
Z
∫
Z
χ(x, z, z′)p(z′)Q(x)dz′dz.
We still have to specify the growth rate µ and the integral kernel χ in order to obtain a closed form
equation. To this aim we expand µ about M0:
µ(x,M,v) = µ(x,M0,v) + ∂Mµ(x,M0,v)(M −M0) +O(|M −M0|2)
Recognizing that M −M0 =
∞∑
i=1
iMi = O(), the equation involving the second powers of  reads as:
∂tm0 +∇ · (vm1) = −λ0m2 + λ1mz2 + λ0
q
ω
M2 − λ1 q
ω
Mz2 + µ(x,M0,v)Q(x)
∫
Z
∫
Z
χ(x, z, z′)p(z′)dz′dz.
We assume χ(x, z, z′) to be a probability kernel with respect to z for all (x, z′), meaning that there is
some probability distribution independent of the space variable and the integrin bindings describing the
state of the cell previous to a proliferation event. Then we have∫
Z
∫
Z
χ(x, z, z′)p(z′)dz′ dz =
∫
Z
p(z′) dz′ = m0 +O(),
which leads to the closed form 2 equation
∂tm0 +∇ · (vm1) = −λ0m2 + λ1mz2 + λ0
q
ω
M2 − λ1 q
ω
Mz2 +Q(x)µ(x,M0,v)m0. (9)
Now we can compute the quantities involved in the system of equations. By integrating the 0 equations
with respect to v, it immediately follows that Mz0 = 0, so by the second equation m
z
0 = 0. Inserting this
into the first equation yields m0 =
q
ωM0.
Now integrating the 1 equations with respect to v and recalling the assumption of undirected fibers we
obtain the following auxiliary system:
∇ ·
∫
V
v
q
ω
M0 dv
 = 0
0 = −(k+Q+ k−)Mz1 + f ′(Q)∇Q ·
∫
V
v
q
ω
M0 dv.
The second equation simplifies to Mz1 = 0. Then we can compute m
z
1 as
mz1 = (k
+Q+ k− + λ0)−1(f ′(Q)∇ · (vQ)m0).
Now we use the properties of the compact Hilbert-Schmidt operator L[λ0](m1) = −λ0m1 + λ0 qωM1
defined on the weighted space L2q(V ), with weight function q
−1(vˆ). For this operator we can find on 〈q〉⊥
a pseudoinverse, and get M1 = 0, hence
m1 = −λ−10
(
∇ ·
(
v
q
ω
M0
)
− λ1(k+Q+ k− + λ0)−1f ′(Q)v · ∇Q q
ω
M0
)
.
For more details we refer to [27, 18].
To summarize, we computed the following quantities:
m0 =
q
ω
M0 (10)
mz0 = 0 (11)
Mz0 = 0 (12)
m1 = − 1
λ0
(
∇ ·
(
v
q
ω
M0
)
− λ1mz1
)
(13)
mz1 =
f ′(Q)
k+Q+ k− + λ0
∇ ·
(
vQ
q
ω
)
M0 (14)
M1 = 0 (15)
Mz1 = 0. (16)
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Now integrating the above 2 equation (9) with respect to v yields∫
V
(
∂t(
q
ω
M0) +∇ · (vm1)
)
dv = Q(x)
∫
V
µ(x,M0,v)m0 dv,
which with the functions calculated above leads to the macroscopic equation
∂tM0 −∇∇ : (DTM0) +∇ · (g(Q(x))DT∇QM0) = Q(x)µ(x,M0)M0, (17)
where we assumed µ not to depend on v explicitly. The function g(Q(x)) := λ1(k
+Q+k−+λ0)−1f ′(Q(x))
carries the information from the subcellular dynamics of receptor binding and
DT (x) =
1
λ0ω
∫
V
qv ⊗ v dv (18)
is the tumor diffusion tensor. Equation (17) is a short form of
∂tM0 −∇ · (DT (x)∇M0) +∇ · (g(Q(x))DT (x)∇Q(x)− u(x))M0) = Q(x)µ(x,M0)M0, (19)
with the drift velocity
u(x) =
1
λ0ω
∫
V
v ⊗ v∇q dv. (20)
3.2 Well-posedness of the macroscopic model
Due to the model complexity we cannot rigorously prove the convergence of the mesoscopic equation (6)
to the macroscopic one (17). Thus, it is not offhand clear whether the existence and uniqueness result
obtained for (6) carries over to the equation deduced on the macroscale and we have to check whether
(17) together with some adequate initial condition is well posed. To this aim we will use the theory of
monotone operators and follow [43, 44]. We will consider here the problem on a bounded domain Ω ⊂ R3
with ∂Ω ∈ C0,1, which then can be extended to the full space R3.
We consider the following problem:
∂tw −∇ · (DT∇w) +∇ · (Υ(Q,DT )w)− Γ(w) = 0 in [0, T ]× Ω (21)
∇w · n = 0 on [0, T ]× ∂Ω, (22)
w(0) = w0 in Ω, (23)
with a finite T > 0 and Ω as above, Γ(w) := Q(x)µ(x, w)w, and Υ(Q,DT ) := g(Q(x))DT (x)∇Q(x)−u(x).
Set U := H1(Ω), H := L2(Ω), and X := L2(0, T ;H1(Ω)). We define for all w, ζ ∈ X:
〈A1w, ζ〉X :=
∫ T
0
∫
Ω
(DT∇w −Υ(Q,DT )w) · ∇ζ dxdt =: 〈Aw, ζ〉X + 〈A˜w, ζ〉X ,
〈A2w, ζ〉X := −
∫ T
0
∫
Ω
Γ(w)ζ dxdt.
Subsequently we require the continuous function Γ : R→ R to satisfy the following conditions:
|Γ(s)| ≤ C(1 + |s|r−1) for some finite r ≥ 1, (24)
inf
s∈R
Γ(s)s > −∞ (25)
and the tensor DT (x) to be positive definite for a.e. x and have its smallest eigenvalue larger then some
α > 0. Moreover, DT should be in L∞(Ω). 4
Theorem 3.1 Let w0 ∈ L2(Ω) and the continuous function Γ : R→ R satisfy the conditions (24), (25),
with 1 ≤ r < 103 . Then there exists a solution w in
W := {w ∈ L2(0, T ;H1(Ω)) : wt ∈ L2(0, T ; (H1(Ω))∗)}
4These conditions are actually satisfied by the tumor diffusion tensor obtained via (18) from the DTI data.
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of the problem (21)-(23), i.e. for all ζ ∈ C∞0 ([0, T ]× Ω) it holds that∫ T
0
〈dw(t)
dt
, ζ(t)〉H1(Ω)dt+
∫ T
0
∫
Ω
(DT∇w(t)−Υ(Q,DT )w(t)) · ∇ζ dxdt+
∫ T
0
∫
Ω
Γ(w(t))ζ(t) dxdt = 0.
(26)
The proof requires some preliminary results:
Lemma 3.1 The operator A1 maps X into its dual X
∗. The operator A : X → X∗ is strictly monotone,
coercive, bounded, and continuous. The operator A˜ : X → X∗ is continuous and bounded.
Proof: This is straightforward, due to the properties of DT and the concrete form of Υ(Q,DT ) involving
Q,DT , and the drift velocity u given in (29).
As W ⊆ X, we also have that A : W →W ∗ has the properties of A : X → X∗. 
Lemma 3.2 There exist some constants β, δ > 0 5 such that the following coercivity condition holds for
the operator A1 : X → X∗:
〈A1w,w〉X ≥ δ‖∇w‖2L2(0,T ;L2(Ω)) − γ‖w‖2L2(0,T ;L2(Ω)). (27)
Proof: This is again an easy computation relying on the concrete form of Υ(Q,DT ) and the fact that
Q and DT are uniformly bounded. 
Remark 3.1 Inequality (27) differs from the usual coercivity condition. Observe, however, that by de-
noting ω := e−γtw we obtain an equivalent problem
∂tω −∇ · (DT∇ω) +∇ · (Υ(Q,DT )ω) + γω − Γ(ω) = 0 in [0, T ]× Ω. (28)
The operator A˜1 defined by
〈A˜1ω, ζ〉X := 〈A1ω, ζ〉X + γ
∫ T
0
∫
Ω
ωζ dxdt
now satisfies the usual coercivity condition
〈A˜1ω, ω〉X ≥ δ‖∇ω‖2L2(0,T ;L2(Ω)).
In the following we will use equation (28) and the operators A˜1, A2. Observe that in virtue of Lemma
3.1 the operator A˜1 : W →W ∗ is continuous, strictly monotone, coercive, and bounded.
Lemma 3.3 Let Γ satisfy (24) and (25). If r ≤ 103 , then A2 maps W into its dual W ∗ and is bounded.
For r < 103 the operator A2 is strongly continuous.
Proof: See Lemma 3.103, Chapter 3 in [43]. 
Lemma 3.4 Under the above conditions the operator A˜1 +A2 : W →W ∗ is coercive.
Proof: See Lemma 3.105, Chapter 3 in [43]. 
Now the proof of Theorem 3.1 follows as in [43], Theorem 3.106, Chapter 3 (see also the remark thereafter)
and Section III.4.1. in [44].
Proposition 3.1 The above solution of the macroscopic problem is unique, provided the function µ(x, ·)
is Lipschitz continuous.
Proof: This follows with the usual estimates, by a simple application of Gronwall’s inequality and using
Lemma 3.2 and Remark 3.1. 
Proposition 3.2 The solution of the macroscopic problem (21)-(23) with w0 ≥ 0 is nonnegative.
Proof: Take ω = ω+ − ω−, ω ∈ W and test (28) with ω−, then apply Gronwall’s inequality to deduce
ω− = 0.

5depending on the L∞-bound of Υ(Q,DT )
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4 Assessment of parameters and coefficient functions
For the numerical simulation we also have to specify the necessary parameters. We rely on DTI mea-
surements 6. The preprocessed data include segmentation data, apparent water diffusion tensors, and a
brainmask for each voxel of the brain of a healthy adult. All numerical simulations are performed on this
particular brain structure, assuming a (superimposed) initial tumor. The DTI measurements provide
valuable information about the structure of the main coefficients in the macroscopic equation (17). They
allow to explicitly compute the tumor diffusion tensor DT in (18) and the drift velocity in (29) with the
aid of the water diffusion tensor DW . Moreover, they also allow to estimate the fiber orientation and the
volume fraction Q (see subsections 4.1 and 4.2 below).
4.1 Estimating the fiber orientation
To determine the diffusion coefficient in (19) we need to choose the fiber density q in equation (18) for
the tumor diffusion tensor. As in [18, 19] we consider the so-called peanut distribution
q(x,θ) =
n
|Sn−1|tr(DW (x))θ
TDWθ,
where DW denotes the DTI-measured water diffusion tensor. Then (see [18]) the tumor diffusion tensor
in (18) can be computed as
DT (x) =
s2
λ0(n+ 2)
(
I + 2
DW (x)
tr(DW (x))
)
and the drift velocity 20 takes the concrete form
u(x) =
2s2
λ0(n+ 2)
(∇ · DW (x)
trDW (x)
− DW (x) · ∇ trDW(x)
(trDW (x))2
)
, (29)
where s denotes the average cell speed, which is assumed to be constant. It has also been argued [42]
that a bimodal von Mises-Fisher distribution may be more appropriate to model the dependence of q on
DW . In this case q takes the form [39]
q(x,θ) =
k(x)
8pi sinh(k(x))
(exp(k(x)φ · θ) + exp(−k(x)φ · θ)) , (30)
where k(x) = κFA(x) with the fractional anisotropy FA and a real constant κ to be determined. The
vector φ represents the leading eigenvector of the diffusion tensor for each voxel. The main problem with
this choice is the value of κ, as for different choices of it we can obtain more (for large κ) or less (for
smaller κ) pronounced anisotropic behavior. Moreover, it is not clear how to measure such parameter in
the present context, hence we will not use this distribution for our simulations, except for a comparison
between our model and the one using it in [42].
4.2 Estimating the volume fraction of tissue fibers
In previous works [18, 19] the macroscopic quantity Q was chosen to be the fractional anisotropy, which is
assessed from measurements. The argumentation was that the volume fraction Q of brain matter should
be high where the tissue is strongly aligned. While this seems to be true for highly anisotropic regions,
this choice may become problematic in regions consisting of isotropic (non-aligned) and densely packed
tissue. This motivates to look for an alternative estimation of this quantity.
The characteristic (diffusion) length lc is defined as
√
tr(DW )tc and represents the mean free space in
every direction. Hence the space occupied inside a a cube volume V is obtained as V − l3c , i.e., the
maximal volume minus the free space portion. We still need an estimate for the characteristic time tc
and we aim to obtain it from the DTI data. We consider it to be the expected exit time from the volume
V of a particle starting in the center and moving randomly according to the DTI diffusion tensor. After
a normalization of Q by division with the volume V we get the overall representation Q(x) = 1− l3c(x)V .
6provided by Carsten Wolters (Institute for Biomagnetism and Biosignal Analysis, WWU Mu¨nster)
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4.3 Selecting the growth rate
There is a large variety of choices which can be made for the growth rate. In the absence of biological data
every such choice is arguable and we have to rely on different existing model types. Hence, reasonable
choices of µ are
µ1(M0) = cg
(
1− M0
CM
)
or
µ2(M0) = −cg ln
(
M0
CM
)
.
The former corresponds to logistic growth of a population with carrying capacity CM ; this choice and has
been made e.g., in [33, 51]. The other choice µ2 describes Gompertzian growth, which has been preferred
due to better fitting of growth data, especially among avascular tumor growth power law (see e.g. [2]
and the references therein). However, it is still lacking a truly fundamental explanation. The best choice
of the growth model (also beyond Gompertz vs. logistic) is yet a controversial issue.
4.4 Selecting the remaining constants
The following table specifies the rest of the involved constants:
Parameter Value Source
R0 10
5 [5]
s 0.21 · 10−6ms [10]; we used 0.25 · 10−6ms
λ0 0.1
1
s [45]
λ1 0.01
1
s as in [18]
k+ 0.1 1s as in [18], assumed to equal the dettachment rate
(or be comparable, to the same order of magnitude)
k− 0.1 1s [36]
cg ≈ 8.44 · 10−7 1s− ≈ 1.01 · 10−6 1s estimated as below.
cM ≈ 1 estimated.
Table 1: Model parameters
For the value of the constant cg we have either to rely on measurements or estimate it with the aid of the
duration of a cell cycle. The first method is widely accepted and used, however it has some shortcomings.
For example, the (tumor) volume doubling rate is known by measurements, but this value only gives
the visible size (up to 80%) and moreover it is not directly connected to the tumor cell density, hence
the error done is twofold. It is known that GBM tumors in particular show a highly migratory behavior
and so the moving cells which got far enough from the tumor are not counted. Furthermore, the visible
tumor is heterogeneous with respect to its cells and even with respect to their density, making the reliable
assessment of cg via measurements a very difficult task.
The second possibility directly relates to the cell type. We used for the cell cycle duration 205200s, hence
about 57 hours - corresponding to the mean cell cycle measured in [31] Then the rate would be ln(2)205200s .
But this value is not the correct one, because not every cell in a tumor is actively going through its cycle;
most of the tumor cells are actually in a quiescent phase, in which they rest and interrupted division,
see, e.g., [1]. In [49] the authors estimated the fraction of actively cycling cells between 25% and 30%.
This leads to cg =
fraction of actively cycling cells
duration of a cell cycle · ln 2.
5 Numerical simulations
We solve the macroscopic equation (19). All involved coefficients are calculated using the octave numerics
software. Then the simulation of the PDE is implemented via DUNE [4].
The coefficients DT and the drift term are spatially dependent, so we expect regions of the computational
domain that are dominated by the diffusion term and others dominated by the drift term. Thus we need
numerical methods capable to handle both diffusion dominated and degenerated parabolic equations.
Moreover, the selected method has to handle full tensors and should be locally mass conservative.
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5.1 Implementation
For the simulation we use a parallel structured quadrilateral mesh as implemented in YaspGrid of DUNE.
The cells are chosen in such a way that we have a subset of the voxel mesh given by the DTI dataset we
use, so that we can really compute only on the regions of the brain consisting of white and gray brain
matter. The segmentation of the brain was given in the dataset. On this mesh we use a symmetric interior
penalty discontinuous Galerkin method as implemented in DUNE [4]. The drift term is computed in a
continuous fashion as a Raviart-Thomas RT0 approximation and the tumor diffusion tensor is constant
over one computational cell. Moreover, to be robust with respect to heterogeneous diffusion, we use
weighted jumps in the discretization. More details on the discretization can be found e.g., in [18, 20].
For the time discretization we use an implicit Euler scheme with a step size τ satisfying a CFL-condition
near 1. In our case we have selected τ to be about half a day.
5.2 Results for the model (19)
The simulation results for the model (19) performed in a 2D domain representing a single slice of a human
brain (from our data sets) are shown in Figure 1 for the logistic growth case (hence with the growth rate
µ1(M0)) and in Figure 4 for the Gompertzian growth case (with growth rate µ2(M0)), respectively.
As in [18, 19], notice that the tumor cells follow the anisotropic structure of the brain white matter.
Figure 2 shows the structure of the computational brain slice when the volume fraction of tissue fibers is
represented by the (arguable) choice of fractional anisotropy as assessed from DTI measurements (left)
and by the estimation done in Subsection 4.2 (right).
Our model applied to the case with fractional anisotropy predicts a much faster glioma spread, while
the choosing the estimated Q for the volume fraction of tissue fibers shows an enhanced, however more
localized growth, as illustrated more clearly in Figure 3.
Day 0 Day 200 Day 400 Day 600
(a) Simulation results for (19) with fractional anisotropy and logistic growth
Day 0 Day 200 Day 400 Day 600
(b) Simulation results for (19) with the estimated Q and logistic growth
Figure 1: Simulation results for (19) with growth function µ1
5.3 Comparison between our new model and previous approaches
Figure 5 illustrates the difference between the solution behavior for the model studied here (describing
cell proliferation as in (5)) and the one for model previously introduced in [19] to comply with the “go-or-
grow” hypothesis. Observe that the new model predicts a larger extent of tumor spread and the difference
between the two models becomes more accentuated with evolving time.
Compared to pure diffusion models as in e.g., [33, 47, 51] involving constant or space-varying diffusion
coefficients, our multiscale approach leading to a supplementary drift term predicts a more anisotropic
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(a) Fractional anisotropy (b) Estimated Q
Figure 2: Fractional anisotropy and the estimated Q in the computational slice.
(a) Day 280 (b) Day 560
Figure 3: Difference M0(Q)−M0(FA) between the simulation done with the estimated Q and with
fractional anisotropy, respectively; logistic growth case.
cancer spread, following the white matter structure. This is in accordance to the findings in [18, 19].
Figure 6 illustrates this difference. Thereby, the pure diffusion model has the form
∂tM0 −∇ · (DT (x)∇M0) = Q(x)µ(x,M0)M0.
Notice that the above model (although with the diffusion coefficient involving DT computed from the
DTI data at each space point x) substantially overestimates the tumor growth in the more isotropic brain
structure and drastically underestimates glioma invasion at the tumor edges in the anisotropic part. This
might lead to a relatively fast tumor recurrence (e.g., after surgery, due to insufficient resection at the
invasion front).
A similar comparison between the drift-diffusion model
∂tM0 −∇∇ : (DT (x)M0) = Q(x)µ(x,M0)M0
deduced in [42] and the multiscale approach in this paper is presented in Figure 7 below. Thereby,
following [42] we choose for q the von Mises-Fisher distribution in (30) with the concentration κ(x) = κ
taking the values κ = 10, κ = 20, and the very large value κ = 104. The latter means that the
directional distribution of tissue fibers becomes highly concentrated about the angle θ, thus enforcing
anisotropic behavior. Notice that neither this choice can capture the strongly anisotropic (finger-like)
spread predicted by our model (especially at the invasion fronts), although it performs better than the
pure diffusion approach.
11
Day 0 Day 100 Day 200 Day 300
(a) Simulation results for (19) with fractional anisotropy and Gompertz growth
Day 0 Day 100 Day 200 Day 300
(b) Simulation results for (19) with the estimated Q and Gompertz growth
Figure 4: Simulation results for (19) with growth function µ2.
(a) Day 280 (b) Day 560
Figure 5: Difference M0 −N0 between the solutions to the model with cell proliferation as in (5) and
the previous model in [19] relying on the ’go-or-grow’ dichotomy. The growth is characterized with the
aid of µ1 in Subsection 4.3.
5.4 Comparison between 2D and 3D
In order to assess possible implications of a supplementary space dimension we also simulated the model
(19) in three dimensions. Figure 8 shows top and side views of a couple of snapshots for the tumor
evolution. As these simulations are much more expensive than their 2D counterparts we compared the
3D results (more precisely the projection on the corresponding 2D brain slice) with the simulations ob-
tained directly for that particular 2D domain. Figures 9a and 9b show snapshots of the respective tumor
evolution. Notice the high resemblance of the results; the projected 3D case exhibits for longer runs a
slightly enhanced tumor growth (the difference is of the order of 10−2). This shows that the the less costy
2D simulations are already relevant for conclusions about the glioma behavior.
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(a) Day 280 (b) Day 560
Figure 6: Difference M0 − P0 between the solutions obtained by our multiscale approach and the one
using a pure diffusion model set directly on the macroscale, respectively.
6 Discussion and outlook
In this work we proposed a multiscale model for glioma invasion accounting for proliferation on the
mesoscale. As in [19] this constitutes an extension of previous mathematical models where cell prolifera-
tion was modelled directly on the macroscopic level by way of some growth term, mostly of logistic type.
While [19] included proliferation based on the “go-or-grow” dichotomy, the approach at hand offers an
alternative to this sometimes contested assumption (see e.g., [14, 22, 41, 50]) and considers instead cell-
tissue interactions (via cell surface receptors binding to the tissue fibers) as initiators of the cell division
process. These interactions described in (5) feature a growth function µ depending on the macroscopic
cell density, position, and cell velocity, together with a function χ characterizing the innovations of sub-
cellular dynamics according to the cell-tissue interactions. The new model involves a kinetic transport
equation for the glioma cell density on the mesoscale and an ODE for the binding of cell surface recep-
tors to the tissue fibers on the microscale. This two-scale model is globally well posed, by the theory
in [38]. A parabolic scaling argument leads to an effective equation for the tumor cell density on the
macroscale, for which the (local) well posedness is proved. The occurring coefficients (tumor diffusion
tensor, tumor drift velocity, and the transport velocity in the supplementary first order term carrying
the information from the subcellular level) can be explicitly determined with respect to the directional
distribution q of tissue fibers and the volume fraction Q of brain matter and computed/estimated from
DTI data. The simulation results are in accordance with previous findings [18, 19] that glioma follow
white matter tracts, hence leading to the clinically observed finger-like structures [13, 16, 23, 40]. Com-
parisons with pure diffusion or monoscale models show that those predict a more compact shape of the
tumor, thereby underestimating its degree of extent in the direction of white matter tracts. Compared
to our previous model in [19] describing cell proliferation via “go-or-growth”, the current setting predicts
enhanced glioma invasion and growth. To decide which of these models better reproduces the actual
tumor behavior remains a future task, as patient data are needed. 7
There are still several interesting issues to be addressed in connection with this modeling approach. In (5)
we assumed for simplicity that the growth function µ was independent on the subcellular dynamics and
later on we even dropped the dependence on the cell velocity. These dependencies seem to be biologically
related, as the distribution and number of a a cell’s surface receptors bound to the tissue fibers is relevant
both for its velocity and its internal biochemical activity (including proliferation). Hence, handling one of
these issues would implicitly provide some information about the other. This would certainly complicate
the deduction of the macroscopic equation in Subsection 3.1 but would possibly lead to different source
terms on the right hand side of (19). Again, the best choice of µ and how much of the related information
should be accounted for is a matter of data availability.
Therapy modeling is another prominent issue: for instance, the common radiotherapy methods involve
simple statistics in connection with the survival ability of the irradiated tissue. However, such approaches
cannot provide a satisfactory description of the therapy effects on the cell dynamics (recovery of the
damaged cells, proliferation, sensitivity against treatment etc.), hence the need of cell population models
7so far only DTI data for the brain structure of a healthy subject were available for our simulations
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(a) Day 280, κ = 10 (b) Day 560, κ = 10
(c) Day 280, κ = 20 (d) Day 560, κ = 20
(e) Day 280, κ = 10000 (f) Day 560, κ = 10000
Figure 7: Difference M0 − P0 between the solutions obtained by our multiscale approach and the one
using a pure mesoscopic model leading to a macroscale equation with fully anisotropic diffusion,
respectively.
characterizing the behavior of tumor and tissue by way of differential equations or in the framework of hy-
brid discrete/continuous settings. Mathematical models and their simulations can offer an advantageous
platform for investigating the effects, but also the combinations of different types of therapy (surgery,
chemo and radiotherapy) and their scheduling. Thereby, it is desirable to have performant models to
predict the spatial tumor extent over time. Extending our multiscale approach to include therapy issues
is ongoing work.
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(a) Day 140, top view (b) Day 280, top view
(c) Day 140, side view (d) Day 280, side view
Figure 8: 3D Simulations of (19).
discussions about cell motility and related data allowing us to assess some of the parameters involved in
the model.
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